DDAVP (NEEDS NO REFRIGERATION) Drug Patent Profile
✉ Email this page to a colleague
When do Ddavp (needs No Refrigeration) patents expire, and what generic alternatives are available?
Ddavp (needs No Refrigeration) is a drug marketed by Ferring Pharms Inc and is included in one NDA.
The generic ingredient in DDAVP (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ddavp (needs No Refrigeration)
A generic version of DDAVP (NEEDS NO REFRIGERATION) was approved as desmopressin acetate by MEITHEAL on October 15th, 1997.
Summary for DDAVP (NEEDS NO REFRIGERATION)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 18 |
| Clinical Trials: | 23 |
| Patent Applications: | 5 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DDAVP (NEEDS NO REFRIGERATION) at DailyMed |
-patent-expirations.png "DDAVP (NEEDS NO REFRIGERATION) drug patent expirations")
Recent Clinical Trials for DDAVP (NEEDS NO REFRIGERATION)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Naval Medical Center Camp Lejeune | Phase 3 |
| Elisabeth Bruyere Hospital | Phase 1/Phase 2 |
| Providence Hospital | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DDAVP (NEEDS NO REFRIGERATION)
US Patents and Regulatory Information for DDAVP (NEEDS NO REFRIGERATION)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | DDAVP (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 017922-003 | Aug 7, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DDAVP (NEEDS NO REFRIGERATION)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | DDAVP (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 017922-003 | Aug 7, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
| Ferring Pharms Inc | DDAVP (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 017922-003 | Aug 7, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
| Ferring Pharms Inc | DDAVP (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 017922-003 | Aug 7, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DDAVP (NEEDS NO REFRIGERATION)
See the table below for patents covering DDAVP (NEEDS NO REFRIGERATION) around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 2166296 | COMPOSITIONS PHARMACEUTIQUES STABILISEES A BASE DE PEPTIDES (STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS) | ⤷ Try a Trial |
| China | 1126440 | ⤷ Try a Trial | |
| Mexico | 9710103 | DESMOPRESINA DE ALTA PUREZA PRODUCIDA EN GRANDES LOTES SIMPLES. (HIGH PURITY DESMOPRESSIN PRODUCED IN LARGE SINGLE BATCHES.) | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DDAVP (NEEDS NO REFRIGERATION)
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2712622 | LUC00015 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101 |
| 3225249 | CA 2019 00023 | Denmark | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504 |
| 3225249 | 2019C/520 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
